<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have examined peripheral blood or bone marrow DNA following allogeneic bone marrow transplantation (BMT) in children suffering from a variety of <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">haematological disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Using either locus-specific minisatellite probes separately or in combination with a Y specific probe for sex-mismatched transplants, complete haematological chimaerism, autologous reconstitution, or mixed chimaeric states have been defined immediately post-BMT </plain></SENT>
<SENT sid="2" pm="."><plain>We have also been able to identify emerging autologous cells or relapse prior to morphological diagnosis </plain></SENT>
<SENT sid="3" pm="."><plain>Forty-two children, mean age 6.4 years (range 9 months to 15 years), received an allogeneic BMT for: <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (ALL), n = 17; <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), n = 5; <z:mpath ids='MPATH_503'>biphenotypic leukaemia</z:mpath>, n = 1; <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), n = 5; <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_338'>granulocytic leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CGL</z:e>), n = 1; severe aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> (SAA), n = 7; <z:e sem="disease" ids="C0272199" disease_type="Neoplastic Process" abbrv="FHL|FEL|HPLH1|FHLH|HPLH|HLH1">familial erythrophagocytic lymphohistiocytosis</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FEL</z:e>), n = 2; <z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">beta thalassaemia major</z:e> (beta thal), n = 1; and juvenile <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JCML</z:e>), n = 3 </plain></SENT>
<SENT sid="4" pm="."><plain>Immediately post-transplant, 78% had achieved complete haematological chimaerism, 12% had failed to engraft (DNA analysis confirmed autologous reconstitution) and 10% had mixed chimaerism </plain></SENT>
<SENT sid="5" pm="."><plain>SAA was the underlying disease in two of the chimaeric cases, the third case having had a matched unrelated donor (MUD) BMT for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In 3/4 cases which subsequently relapsed, DNA analysis showed re-emergence of autologous cells (indicative of relapse), prior to their morphological identification </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that DNA analysis using minisatellite probes to assess graft status provides a useful contribution to patient management following allogeneic BMT </plain></SENT>
</text></document>